NEUROCRINE BIOSCIENCES INC Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Neurocrine Biosciences Inc quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • Neurocrine Biosciences Inc Return On Assets for the quarter ending September 30, 2024 was 11.4 %, a 51.7% increase year-over-year.
  • Neurocrine Biosciences Inc annual Return On Assets for 2023 was 9.02 %, a 26.5% increase from 2022.
  • Neurocrine Biosciences Inc annual Return On Assets for 2022 was 7.13 %, a 57% increase from 2021.
  • Neurocrine Biosciences Inc annual Return On Assets for 2021 was 4.54 %, a 82.9% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 9.02 +1.89 +26.5% Jan 1, 2023 Dec 31, 2023
2022 7.13 +2.59 +57% Jan 1, 2022 Dec 31, 2022
2021 4.54 -22.1 -82.9% Jan 1, 2021 Dec 31, 2021
2020 26.6 +23.4 +712% Jan 1, 2020 Dec 31, 2020
2019 3.28 +0.92 +39% Jan 1, 2019 Dec 31, 2019
2018 2.36 +24 Jan 1, 2018 Dec 31, 2018
2017 -21.7 +12.5 +36.6% Jan 1, 2017 Dec 31, 2017
2016 -34.1 -16.4 -92.5% Jan 1, 2016 Dec 31, 2016
2015 -17.7 +5.34 +23.1% Jan 1, 2015 Dec 31, 2015
2014 -23.1 +4.06 +15% Jan 1, 2014 Dec 31, 2014
2013 -27.1 -29.6 -1182% Jan 1, 2013 Dec 31, 2013
2012 2.51 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.